6 completed, 2 active not recruiting. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Active not recruiting 2 |
| Phase 2 | 2 | Completed 2 |
Follow Bird Diseases: new trials by email Literature Review of Bird Diseases trials Research Report on Bird Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults mRNA-1018-H5, Placebo - Influenza | Phase 3 | Active not recruiting | ModernaTX, Inc. | 4050 | 2026-03-23 | 2026-08-11 |
| Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial) H5N1 vaccine (Arepanrix, GSK), Placebo - Influenza (Pandemic), Avian Influenza | Phase 3 | Active not recruiting | University Health Network, Toronto | 120 | 2025-11-03 | 2026-10-23 |
| A Safety and Immunogenicity Study of IVACFLU-A/H5N1 IVACFLU-A/H5N1 vaccine, Placebo - Avian Influenza | Phase 2 / Phase 3 | Completed | Institute of Vaccines and Medical Biologicals, Vietnam | 930 | 2017-03-07 | 2019-05-21 |
| A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age aH5N1c, Placebo - Avian Influenza | Phase 3 | Completed | Seqirus | 3196 | 2016-07-11 | 2024-12-06 |
| Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions Novartis Investigational H5N1 vaccine, Novartis Seasonal Influenza Vaccine - Influenza, Human | Phase 3 | Completed | Seqirus | 540 | 2014-04-01 | 2016-11-04 |
| Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine Novartis Investigational H5N1 vaccine, Novartis Seasonal Influenza Vaccine - Influenza, Human, Flu, Human | Phase 3 | Completed | Seqirus | 539 | 2014-04-01 | 2016-05-09 |
| Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers MG1109, Placebo - Influenza | Phase 3 | Completed | Green Cross Corporation | 420 | 2013-08-01 | 2015-07-03 |
| H5N1 Vaccine Study in Japanese Adults H5N1 (pre-)pandemic influenza vaccine (whole virion, Vero Cell derived, inactivated) - H5N1 Influenza | Phase 2 / Phase 3 | Completed | Alachua Government Services, Inc. | 340 | 2011-06-01 | 2015-10-09 |
Influenza in Birds (8) · Influenza, Human (6) · Virus Diseases (1)
Animal Diseases (8) · Infections (8) · Orthomyxoviridae Infections (8) · RNA Virus Infections (8) · Virus Diseases (7) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6)
arepanrix (1) · halofantrine (1)
Seqirus (3) · Alachua Government Services, Inc. (1) · Green Cross Corporation (1) · Institute of Vaccines and Medical Biologicals, Vietnam (1) · ModernaTX, Inc. (1) · University Health Network, Toronto (1)
Germany (2) · United States (2) · Australia (1) · Canada (1) · Italy (1) · Japan (1) · South Korea (1) · United Kingdom (1) · Vietnam (1)
Alexander Geisberger, MD (1) · Tran N Duong, MD, PhD (1) · Woo Joo Kim, MD, Ph.D (1)